News
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
23 September 2026
Dharma Dexa Implements “Deal with Care” for Disaster-Affected Communities in 2026
JAKARTA — Amid a series of natural disasters impacting various regions across Indonesia throughout 2026, Dexa Group, through its Corporate Social Initiative Dharma Dexa, continues to strengthen its commitment to safeguarding health and inspiring hope for affected communities. This step marks part of Dexa Group's 57th-anniversary spirit to extend meaningful…
2 October 2025
More Than 1,500 Residents Join Dexa Medica’s Free Health Check, Reinforcing Commitment to Quality and Halal Medicine Access
Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga…
24 September 2025
Building Reputation through The Reflection of Quality, Dexa Medica Wins Indonesia Most Reputable Companies Award 2025
Dexa Medica has once again received the prestigious Indonesia Most Reputable Companies Award 2025 from SWA Magazine and Business Digest. This marks the second time Dexa Medica has earned this recognition, reaffirming the company’s commitment to building and maintaining its reputation as a reflection of quality. The award was presented…
24 September 2025
Reflection of Quality and Innovation in Industry 4.0, Dexa Medica Wins Rintek 2025 Award
Dexa Medica has been awarded the 2025 Industrial Technology Pioneer Award (Rintek) in the category of Technology Pioneer Evaluation Results by the Ministry of Industry of the Republic of Indonesia. The award recognizes the success of Inlacin, an Indonesian Original Modern Medicine for diabetes, as a clinically proven global innovation…
24 September 2025
Dexa Medica Health Screening Program: Early Detection of Hypertension, Diabetes, and Cholesterol
Non-Communicable Diseases such as hypertension, diabetes, and high cholesterol are increasingly threatening public health in Indonesia. According to the Ministry of Health of the Republic of Indonesia, these three silent diseases are among the leading contributors to the national health burden and are often detected only when it is too…
15 August 2025
Dexa Group Wins Indonesia PR of The Year 2025, A True Reflection of Quality
JAKARTA — Strategic and impactful public communication has once again placed Dexa Group on the national stage. The pharmaceutical company has been named Indonesia PR of The Year 2025 by MIX MarComm magazine. The award was presented by MIX MarComm’s Editor-in-Chief, Ms. Lis Hendriani, to Dexa Group’s Head of Corporate…
15 August 2025
Commitment to ESG, Dexa Group Secures Green Economy Award for Green Pharmacy
JAKARTA — Dexa Group’s consistent commitment to sustainability in the pharmaceutical sector has earned the company the Anugerah Ekonomi Hijau (Green Economy Award) from Indonesia national media, detikcom. The award was given in the Green Pharmacy category for the development of Obat Modern Asli Indonesia (OMAI), which combines pharmaceutical innovation…
12 August 2025
Dexa Group Forms Strategic Alliance with AC Health to Expand Access to Quality and Affordable Generic Medicines in the Philippines
MANILA — AC Health has formed a strategic alliance with Glorious Dexa Mandaya Philippines, a subsidiary of the Indonesian pharmaceutical company Dexa Group, to enhance the availability of quality and affordable medicines for Filipinos. The partnership will focus on distributing Dexa Group’s affordable medicines and healthcare products, leveraging AC Health’s…